MEMOX 20

Land: Israel

Sprog: engelsk

Kilde: Ministry of Health

Køb det nu

Indlægsseddel Indlægsseddel (PIL)
09-01-2022

Aktiv bestanddel:

MEMANTINE HYDROCHLORIDE

Tilgængelig fra:

UNIPHARM LTD, ISRAEL

ATC-kode:

N06DX01

Lægemiddelform:

FILM COATED TABLETS

Sammensætning:

MEMANTINE HYDROCHLORIDE 20 MG

Indgivelsesvej:

PER OS

Recept type:

Required

Fremstillet af:

TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD, ISRAEL

Terapeutisk gruppe:

MEMANTINE

Terapeutisk område:

MEMANTINE

Terapeutiske indikationer:

Treatment of patient with moderately severe to severe Alzheimer's disease.

Autorisation dato:

2016-04-30

Indlægsseddel

                                PATIENT PACKAGE INSERT
IN ACCORDANCE WITH THE
PHARMACISTS' REGULATIONS
)PREPARATIONS( – 1986
The medicine is dispensed with
a doctor’s prescription only
MEMOX TABLETS
10, 20 MG
COMPOSITION:
Each MEMOX 10 tablet contains:
Memantine hydrochloride 10 mg
Each MEMOX 20 tablet contains:
Memantine hydrochloride 20 mg
INACTIVE AND ALLERGENIC INGREDIENTS IN
THE PREPARATION: see section 2 “Before
using the medicine” and section 6 “Further
information”.
READ THE LEAFLET CAREFULLY IN ITS ENTIRETY
BEFORE USING THE MEDICINE. This leaflet
contains concise information about the
medicine. If you have further questions,
refer to the doctor or pharmacist.
This medicine has been prescribed for the
treatment of your ailment. Do not pass it on
to others. It may harm them even if it seems
to you that their ailment is similar.
1. WHAT IS THE MEDICINE INTENDED
FOR?
MEMOX is intended for the treatment of
moderate to severe Alzheimer’s disease.
MEMOX belongs to a group of medicines
for the treatment of dementia. The memory
loss characteristic of Alzheimer’s disease
is caused by disruption of the transmission
of nerve signals in the brain. There are
receptors in the brain called NMDA
receptors. These receptors are involved
in transmission of nerve signals which
are important for learning and memory.
MEMOX acts on NMDA receptors, thereby
improving transmission of nerve signals
and memory.
THERAPEUTIC GROUP: NMDA receptor
antagonist.
2. BEFORE USING THE MEDICINE
DO NOT USE THE MEDICINE IF:
You are sensitive )allergic( to the active
ingredient or to any of the additional
ingredients contained in the medicine )see
list of inactive ingredients in section 6(.
118438010
05B21
SPECIAL WARNINGS REGARDING USE OF THE
MEDICINE
BEFORE TREATMENT WITH MEMOX, TELL THE
DOCTOR IF:
• You have a history of epilepsy )epileptic
attacks(.
• You recently suffered from a myocardial
infarction )heart attack(, or if you are
suffering from heart failure or from
uncontrolled hypertension. In the above-
mentioned situations, the doctor will
carefully
                                
                                Læs hele dokumentet
                                
                            

Dokumenter på andre sprog

Indlægsseddel Indlægsseddel arabisk 09-01-2022
Indlægsseddel Indlægsseddel hebraisk 09-01-2022

Søg underretninger relateret til dette produkt

Se dokumenthistorik